South Korea based International Vaccine Institute (IVI) and the Future Investment Initiative Institute (FII-I) in Saudi Arabia have signed a memorandum of understanding (MoU) to increase awareness and muster support to tackle infectious diseases.

IVI and FII-I will endeavor to pursue strategic collaborations with each other, working together on topics that create value for both organizations within healthcare, more specifically within the field of infectious diseases.

Dr. Jerome Kim, Director General of IVI, and Rakan Tarabzoni, Chief Operating Officer of the FII-I, signed the agreement on March 24 from Seoul, South Korea and Riyadh, Saudi Arabia.

This MOU will create further opportunities for IVI and FII-I to continue developing and publishing content about vaccines and their role in strengthening global health.

“IVI welcomes this new partnership with the FII Institute to mobilize support and advocacy for vaccines against highly problematic infectious diseases such as tuberculosis, exchange information and global health networks, and co-create research on the value of vaccines,’’ said Dr. Jerome Kim.

“The agreement reflects the FII Institute’s eagerness to contribute at large scale to the global dialogue on healthcare. We look forward to a fruitful collaboration on tackling global health issues and raising awareness about potential solutions for them’’, said Richard Attias, CEO of the FII-I.